Arena Pharmaceutical Inc. (ARNA) Is Surging On Phase 2 Study Results
Arena Pharmaceutical Inc. (ARNA) announced after the bell Monday that its Phase 2 study of etrasimod met its primary and all secondary endpoints with statistical significance for patients receiving 2 mg dose.
Source: RTTNews